MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from sales and
maturities of marketable...
$57,071K
Proceeds from stock
option exercises, net...
$3,984K
Proceeds from purchases
under the employee...
$2,537K
Net cash provided by
(used in) investing...
$4,542K
Net cash provided by
(used in) financing...
$760K
Canceled cashflow
$52,529K
Canceled cashflow
$5,761K
Net decrease in
cash, cash...
-$11,757K
Canceled cashflow
$5,302K
something is missing
$71,354K
Stock-based compensation
$23,043K
Trade receivables
-$20,714K
Prepaid expenses and
other current assets
-$4,736K
Accretion of marketable
securities, net
$3,174K
Depreciation and
amortization
$598K
Accrued research and
development expenses
$137K
Purchases of marketable
securities
$52,328K
Purchases of property and
equipment
$201K
Cash paid to satisfy
statutory withholding...
$5,761K
Net cash (used in)
provided by operating...
-$16,772K
Canceled cashflow
$123,756K
Net effect of
exchange rate changes on...
-$287K
Net (loss) income
-$107,125K
Deferred income taxes
-$13,110K
Accrued and other
liabilities, current and...
-$9,377K
Accounts payable
-$7,644K
Inventory
$3,272K
Back
Back
Cash Flow
CORCEPT THERAPEUTICS INC (CORT)
CORCEPT THERAPEUTICS INC (CORT)
source: myfinsight.com